Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab von Dargaud, Yesim, Lienhart, Anne, Janbain, Maissaa, Le Quellec, Sandra, Enjolras, Nathalie, Negrier, Claude

Volltext

Why patients with THBD c.1611C>A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin? von Jourdy, Yohann, Enjolras, Nathalie, Le Quellec, Sandra, Bordet, Jean Claude, Négrier, Claude, Vinciguerra, Christine, Dargaud, Yesim

Volltext

Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding von Leuci, Alexandre, Enjolras, Nathalie, Marano, Muriel, Daniel, Melanie, Brevet, Marie, Connes, Philippe, Dargaud, Yesim

Volltext

Extravascular Factor IX Pool Fed By Prophylaxis Is a True Hemostatic Barrier Against Bleeding von Leuci, Alexandre, Enjolras, Nathalie, Marano, Muriel, Daniel, Melanie, Brevet, Marie, Connes, Philippe, Dargaud, Yesim G.

Volltext

In vivo intranasal delivery of coagulation factor IX: a proof-of-concept study von Fieux, Maxime, Rovera, Renaud, Coiffier, Céline, Colomb, Evelyne, Enjolras, Nathalie, Béquignon, Emilie, Monge, Claire, Le Quellec, Sandra

Volltext

Individually Tailored By-Passing Therapy for the Management of Breakthrough Bleeds in Hemophilia Patients with Inhibitors Receiving Prophylaxis with Emicizumab von Dargaud, Yesim, Lienhart, Anne, Enjolras, Nathalie, Negrier, Claude

Volltext

Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study von Janbain, Maissa, Enjolras, Nathalie, Bordet, Jean-Claude, Bolbos, Radu, Brevet, Marie, Leissinger, Cindy, Dargaud, Yesim

Volltext

Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IX von Le Quellec, Sandra, Enjolras, Nathalie, Perot, Eloïse, Girard, Jonathan, Negrier, Claude, Dargaud, Yesim

Volltext

Characterization of a recombinant factor IX molecule fused to coagulation factor XIII‐B subunit von Desage, Stephanie, Leuci, Alexandre, Enjolras, Nathalie, Holle, Lori A., Singh, Sneha, Delavenne, Xavier, Wolberg, Alisa S., Biswas, Arijit, Dargaud, Yesim

Volltext

Hemostatic Effect of the Combination of Factor VIII Concentrate with Tranexamic Acid (TXA) in the Prophylactic Setting in Severe Hemophilia a von Janbain, Maissaa, Enjolras, Nathalie, Bordet, Jean-Claude, Bolbos, Radu, Leissinger, Cindy A., Dargaud, Yesim

Volltext

Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical study von Janbain, Maissa, Enjolras, Nathalie, Bolbos, Radu, Brevet, Marie, Bordet, Jean‐Claude, Dargaud, Yesim

Volltext

Genetic Fusion to Factor XIII B-Subunit Improves the Pharmacokinetic Properties of Factor IX von Le Quellec, Sandra, Enjolras, Nathalie, Bordet, Jean-Claude, Jacqueline, Vladmir, Negrier, Claude, Dargaud, Yesim

Volltext

Adeno-Associated Virus Mediated Gene Transfer with Hyperfunctional FIX-E410H Variant Improves Mean Factor IX Activity Levels in Hemophilia B Mice von Le Quellec, Sandra, Dane, Allison P, Negrier, Claude, Dargaud, Yesim, Nathwani, Amit C, Enjolras, Nathalie

Volltext

Why patients with THBD c.1611CA von Jourdy, Yohann, Enjolras, Nathalie, Le Quellec, Sandra, Bordet, Jean Claude, Négrier, Claude, Vinciguerra, Christine, Dargaud, Yesim

Volltext

Why patients with THBD c.1611CA nonsense mutation have high levels of soluble thrombomodulin? von Jourdy, Yohann, Enjolras, Nathalie, Le Quellec, Sandra, Bordet, Jean Claude, Négrier, Claude, Vinciguerra, Christine, Dargaud, Yesim

Volltext

Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots von Désage, Stéphanie, Chamouard, Valérie, Meunier, Sandrine, Enjolras, Nathalie, Sobas, Frédéric, Négrier, Claude, Le Quellec, Sandra

Volltext

Potential limits of AAV‐based gene therapy with the use of new transgenes expressing factor IX fusion proteins von Le Quellec, Sandra, Dane, Allison, Enjolras, Nathalie, McIntosh, Jenny, Rosales, Cecilia, Negrier, Claude, Nathwani, Amit

Volltext

A Factor VIII Minigene Comprising the Truncated Intron I of Factor IX Highly Improves the In Vitro Production of Factor VIII von Plantier, Jean-Luc, Rodriguez, Marie-Hélène, Enjolras, Nathalie, Attali, Olivier, Négrier, Claude

Volltext

Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity von Perot, Eloïse, Enjolras, Nathalie, Le Quellec, Sandra, Indalecio, Alice, Girard, Jonathan, Negrier, Claude, Dargaud, Yesim

Volltext

Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications von Enjolras, Nathalie, Dargaud, Yesim, Pérot, Eloïse, Guillaume, Florine, Becchi, Michel, Négrier, Claude

Volltext